Collegium Pharmaceutical, Inc. entered into a Merger Agreement with Carrera Merger Sub Inc. and Ironshore Therapeutics Inc. for a cash consideration of approximately $525 million; also entered into a Second Amended and Restated Loan Agreement for a secured term loan of $645,833,333.